Results 21 to 30 of about 14,468 (240)
Frontiers in Psychiatry, 2021 Clinical studies suggest the therapeutic potential of psychedelics, including ayahuasca, DMT, psilocybin, and LSD, in stress-related disorders. These substances induce cognitive, antidepressant, anxiolytic, and antiaddictive effects suggested to arise ...
Cato M. H. de Vos +2 more
doaj +1 more source
Psychedelics Promote Structural and Functional Neural Plasticity. [PDF]
, 2018 Atrophy of neurons in the prefrontal cortex (PFC) plays a key role in the pathophysiology of depression and related disorders. The ability to promote both structural and functional plasticity in the PFC has been hypothesized to underlie the fast ...
Barragan, Eden V +15 more
core +2 more sources
Frontiers in Psychiatry, 2023 IntroductionThere is substantial public interest in psychedelics as potential treatments for psychiatric conditions. However, most psychedelics are criminalized under federal law in the USA, so it is unclear whether use occurs with clinical support.
Kevin F. Boehnke +17 more
doaj +1 more source
Reaction of N,N-Dimethyltryptamine with Dichloromethane Under Common Experimental Conditions. [PDF]
, 2018 A large number of clinically used drugs and experimental pharmaceuticals possess the N,N-dimethyltryptamine (DMT) structural core. Previous reports have described the reaction of this motif with dichloromethane (DCM), a common laboratory solvent used ...
Dunlap, Lee E, Olson, David E
core +3 more sources
Public Health Research & Practice, 2023 Objectives: This study was aimed at understanding the attitudes and positions of key Australian organisational and political stakeholders towards using psychedelic agents in medically supervised environments to treat mental health conditions ...
Breanne E Kunstler +5 more
doaj +1 more source
Race/ethnicity and gender differences in drug use and abuse among college students [PDF]
, 2007 This study examines race/ethnicity and gender differences in drug use and abuse for substances other than alcohol among undergraduate college students.
Boyd, Carol J. +5 more
core +2 more sources
Psychedelic Cognition—The Unreached Frontier of Psychedelic Science
Frontiers in Neuroscience, 2022 Psychedelic compounds hold the promise of changing the face of neuroscience and psychiatry as we know it. There have been numerous proposals to use them to treat a range of neuropsychiatric conditions such as depression, anxiety, addiction and PTSD; and trials to date have delivered positive results in favor of the novel therapeutics.
openaire +5 more sources
Psychedelics and Personality [PDF]
ACS Chemical Neuroscience, 2018 In the past decade, an increasing number of clinical trials are reporting evidence that psychedelics or serotonergic hallucinogens (such as lysergic acid diethylamide, psilocybin, and ayahuasca/dimethyltryptamine) could be effective in the treatment of mood, anxiety, and substance use disorders.
Marc, Aixalà +3 more
openaire +2 more sources
Frontiers in Psychiatry, 2021 Introduction: The current corona virus disease (COVID-19) pandemic has caused a serious global health crisis that has affected large parts of the public and private life worldwide, including the use of psychoactive substances.
Ricarda Evens +19 more
doaj +1 more source
Psychedelics: A new era of treatment?
European Psychiatry, 2021 Introduction Psychedelics - including LSD (lysergic acid diethylamide), psilocybin, DMT (N, N-dimethyltryptamine), ayahuasca and mescaline - have an ancient history across various civilizations.
S. Torres
doaj +1 more source